Open access
Sep 2026
SDF4 is a potential biomarker for diagnosis and severity assessment in patients with systemic lupus erythematosus
The implementation of refined management of systemic lupus erythematosus (SLE) poses a considerable challenge in clinical practice. In this study, we evaluated serum stromal cell-derived factor 4 (SDF4) as potential biomarkers for SLE diagnosis, disease severity, and prognosis. We determined the SDF4 level...
Xi Chen, Xuan-Zhe Yang, Jing Chen et al.
· BMC Immunology · 0 citations